Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Lyell syndrome is an extended form of toxic epidermal necrolysis characterized by destruction and detachment of the skin epithelium and mucous membranes involving more than 30% of the body surface area.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE1. Research is primarily sponsored by academic and government institutions.
10 publications have been identified in PubMed for Lyell syndrome. Research spans Case Report / Case Series (44%), Review / Meta-Analysis (33%), and Other (22%).
Costa FM (2026). [PMID: 41962283](https://pubmed.ncbi.nlm.nih.gov/41962283/). *Eur J Obstet Gynecol Reprod Biol*. [Other]
Teschke R (2025). [PMID: 40206276](https://pubmed.ncbi.nlm.nih.gov/40206276/). *Journal of clinical and translational hepatology*. [Review / Meta-Analysis]
Barreto F (2025). [PMID: 39897187](https://pubmed.ncbi.nlm.nih.gov/39897187/). *Cureus*. [Case Report / Case Series]
Nafaa M (2025). [PMID: 40585748](https://pubmed.ncbi.nlm.nih.gov/40585748/). *Cureus*. [Case Report / Case Series]
Juenger V (2025). [PMID: 41378969](https://pubmed.ncbi.nlm.nih.gov/41378969/). *Cornea*. [Other]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Lyell syndrome
Paulmann M (2024). [PMID: 39417754](https://pubmed.ncbi.nlm.nih.gov/39417754/). *Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG*. [Review / Meta-Analysis]
Heuer R (2024). [PMID: 39314017](https://pubmed.ncbi.nlm.nih.gov/39314017/). *Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG*. [Review / Meta-Analysis]
Sandakly N (2024). [PMID: 39574993](https://pubmed.ncbi.nlm.nih.gov/39574993/). *Cureus*. [Case Report / Case Series]
Coussirou J (2024). [PMID: 39590140](https://pubmed.ncbi.nlm.nih.gov/39590140/). *Current oncology (Toronto, Ont.)*. [Case Report / Case Series]